Melinda Pruis

Melinda Pruis

Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing.

Back to news

More news

Collaboration for future-proof diagnostics and to accelerate research  

Collaboration for future-proof diagnostics and to accelerate research  

02-05-2023

Complete analysis of the DNA of children with cancer offers many possibilities. It maps out all possible targeted treatment options …

Accreditation renewed

Accreditation renewed

04-01-2021

In October 2020, we received formal notification of the renewal of our accreditation of ISO17025: 2005 into the 2017 version. We …

Complete DNA analysis for young adults with cancer

Complete DNA analysis for young adults with cancer

06-01-2022

KWF finances the expansion of the infrastructure for cancer research in young adults with almost 4.5 million euros. These are …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl